Kornitzer Capital Management Inc Grifols Sa Transaction History

Kornitzer Capital Management Inc

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 01, 2022	SELL	$10.21 - $15.27 $2.64 Million - $3.95 Million	-258,600 Closed	0 $0
Q3 2021 Nov 03, 2021	SELL	$14.07 - $17.3 $23,919 - $29,410	-1,700 Reduced 0.65%	258,600 $3.78 Million
Q1 2021 Apr 30, 2021	SELL	$15.15 - $19.78 $1.52 Million - $1.98 Million	-100,000 Reduced 27.75%	260,300 $4.5 Million
Q4 2020 Jan 29, 2021	SELL	$16.86 - $19.67 $1,686 - $1,967	-100 Reduced 0.03%	360,300 $6.64 Million
Q2 2020 Aug 03, 2020	BUY	$18.24 - $21.45 $583,680 - $686,400	32,000 Added 9.74%	360,400 $6.57 Million
Q1 2020 Apr 30, 2020	BUY	$16.28 - $25.63 $812,372 - $1.28 Million	49,900 Added 17.92%	328,400 $6.61 Million
Q3 2019 Nov 04, 2019	BUY	$19.85 - $22.76 $297,750 - $341,400	15,000 Added 5.69%	278,500 $5.58 Million
Q2 2019 Jul 31, 2019	BUY	$17.59 - $21.1 $175,900 - $211,000	10,000 Added 3.94%	263,500 $5.56 Million
Q1 2019 May 01, 2019	BUY	$18.01 - $20.11 $464,658 - $518,838	25,800 Added 11.33%	253,500 $5.1 Million
Q4 2018 Jan 31, 2019	BUY	$17.44 - $21.53 $547,616 - $676,042	31,400 Added 16.0%	227,700 $4.18 Million
Q3 2018 Nov 13, 2018	BUY	$19.97 - $21.96 $299,550 - $329,400	15,000 Added 8.27%	196,300 $4.2 Million
Q2 2018 Aug 02, 2018	BUY	$20.16 - $24.68 $1.18 Million - $1.44 Million	58,400 Added 47.52%	181,300 $3.9 Million
Q4 2017 Jan 31, 2018	BUY	$20.99 - $23.89 $1.36 Million - $1.55 Million	65,000 Added 112.26%	122,900 $2.82 Million
Q3 2017 Oct 31, 2017	BUY	$20.07 - $21.89 $1.16 Million - $1.27 Million	57,900	57,900 $1.27 Million

164

140M

288K

389K

Ticker GRFS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 678,910,976
Market Cap $5.33B
Description
Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...

Get notified when there are updates to the investment portfolio of Kornitzer Capital Management Inc , based on Form 13F filings with the SEC.

Stay updated on Kornitzer Capital Management Inc with notifications on news.